NexImmune (NEXI) Competitors $0.23 -0.04 (-14.77%) (As of 12/20/2024 04:04 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NEXI vs. PBM, CWBR, ONCT, GRTX, ERNA, SXTC, PBLA, REVB, KRBP, and CYTOShould you be buying NexImmune stock or one of its competitors? The main competitors of NexImmune include Psyence Biomedical (PBM), CohBar (CWBR), Oncternal Therapeutics (ONCT), Galera Therapeutics (GRTX), Eterna Therapeutics (ERNA), China SXT Pharmaceuticals (SXTC), Panbela Therapeutics (PBLA), Revelation Biosciences (REVB), Kiromic BioPharma (KRBP), and Altamira Therapeutics (CYTO). These companies are all part of the "pharmaceutical products" industry. NexImmune vs. Psyence Biomedical CohBar Oncternal Therapeutics Galera Therapeutics Eterna Therapeutics China SXT Pharmaceuticals Panbela Therapeutics Revelation Biosciences Kiromic BioPharma Altamira Therapeutics NexImmune (NASDAQ:NEXI) and Psyence Biomedical (NASDAQ:PBM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, community ranking, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment. Does the media refer more to NEXI or PBM? In the previous week, Psyence Biomedical had 6 more articles in the media than NexImmune. MarketBeat recorded 6 mentions for Psyence Biomedical and 0 mentions for NexImmune. Psyence Biomedical's average media sentiment score of 0.43 beat NexImmune's score of 0.00 indicating that Psyence Biomedical is being referred to more favorably in the news media. Company Overall Sentiment NexImmune Neutral Psyence Biomedical Neutral Does the MarketBeat Community believe in NEXI or PBM? NexImmune received 22 more outperform votes than Psyence Biomedical when rated by MarketBeat users. CompanyUnderperformOutperformNexImmuneOutperform Votes2261.11% Underperform Votes1438.89% Psyence BiomedicalN/AN/A Which has more volatility & risk, NEXI or PBM? NexImmune has a beta of 1.68, indicating that its share price is 68% more volatile than the S&P 500. Comparatively, Psyence Biomedical has a beta of -0.57, indicating that its share price is 157% less volatile than the S&P 500. Is NEXI or PBM more profitable? Psyence Biomedical's return on equity of 0.00% beat NexImmune's return on equity.Company Net Margins Return on Equity Return on Assets NexImmuneN/A -534.32% -213.72% Psyence Biomedical N/A N/A N/A Which has better earnings and valuation, NEXI or PBM? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexImmuneN/AN/A-$32.34M-$18.54-0.01Psyence BiomedicalN/AN/A-$51.16MN/AN/A Do insiders and institutionals hold more shares of NEXI or PBM? 9.9% of NexImmune shares are owned by institutional investors. Comparatively, 77.4% of Psyence Biomedical shares are owned by institutional investors. 14.9% of NexImmune shares are owned by company insiders. Comparatively, 3.6% of Psyence Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryPsyence Biomedical beats NexImmune on 5 of the 9 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEXI vs. The Competition Export to ExcelMetricNexImmunePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$322,000.00$6.57B$5.14B$9.08BDividend YieldN/A2.99%5.09%4.23%P/E Ratio-0.0110.5990.1317.19Price / SalesN/A196.061,116.25117.05Price / CashN/A57.1643.1037.85Price / Book0.075.094.784.78Net Income-$32.34M$151.83M$120.31M$225.60M7 Day Performance0.87%-2.14%-1.92%-1.23%1 Month Performance-37.55%-4.56%13.65%0.46%1 Year Performance-90.04%8.87%28.34%15.24% NexImmune Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEXINexImmuneN/A$0.23-14.8%N/A-89.7%$322,000.00N/A-0.016PBMPsyence BiomedicalN/A$1.87+1.1%N/AN/A$1.58MN/A0.00N/ANews CoveragePositive NewsGap UpCWBRCohBarN/A$0.54-0.1%N/A-28.0%$1.57MN/A0.0010ONCTOncternal Therapeutics2.4303 of 5 stars$0.53flat$10.00+1,799.0%N/A$1.56M$790,000.00-0.0530Analyst ForecastGRTXGalera TherapeuticsN/A$0.03-5.3%N/A-76.3%$1.55MN/A-0.0530Gap DownERNAEterna TherapeuticsN/A$0.28-2.3%N/A-85.4%$1.53M$598,000.00-0.0310Gap DownHigh Trading VolumeSXTCChina SXT Pharmaceuticals0.1727 of 5 stars$0.38-2.5%N/A-82.5%$1.53M$1.93M0.0090Positive NewsGap UpPBLAPanbela TherapeuticsN/A$0.31-2.6%$500.00+159,644.4%-98.1%$1.52MN/A0.007Gap DownREVBRevelation Biosciences0.731 of 5 stars$0.35-2.8%N/A-98.3%$1.50MN/A0.0010KRBPKiromic BioPharmaN/A$0.95flatN/A+162.9%$1.46MN/A-0.1535Gap UpCYTOAltamira Therapeutics1.9288 of 5 stars$0.42-2.5%N/A-90.9%$1.44M$320,000.000.0020News Coverage Related Companies and Tools Related Companies Psyence Biomedical Competitors CohBar Competitors Oncternal Therapeutics Competitors Galera Therapeutics Competitors Eterna Therapeutics Competitors China SXT Pharmaceuticals Competitors Panbela Therapeutics Competitors Revelation Biosciences Competitors Kiromic BioPharma Competitors Altamira Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NEXI) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexImmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEXI Stock Alerts